Results 31 to 40 of about 1,317,378 (148)

Individualization of Antihypertensive Drug Treatment [PDF]

open access: yesDiabetes Care, 2013
Antihypertensive drug classes are usually classified as 1st, 2nd, 3rd, and 4th or 5th choice to help physicians select the drug most suitable for treatment initiation among the very many classes available to lower blood pressure (BP) in patients with a BP elevation.
Mancia, G, Grassi, G
openaire   +2 more sources

COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU

open access: yesРациональная фармакотерапия в кардиологии, 2018
Aim. To study the structure of medical prescriptions of antihypertensive agents for patients with arterial hypertension (HT) in the outpatient practice of Kursk (Russia) and Chisinau (Republic of Moldova).Material and methods.
S. V. Povetkin   +5 more
doaj   +1 more source

Use and pharmaceutical expenditures on antihypertensive and antihyperlipidemic drugs.

open access: yes, 2021
Use and pharmaceutical expenditures on antihypertensive and antihyperlipidemic drugs.
Jihye Shin (714449)   +3 more
core   +1 more source

紫苏籽油的抗衰老作用及机制探究 Anti-aging effect and mechanisms of perilla seed oil

open access: yesZhongguo youzhi
旨在为紫苏籽油的开发利用提供理论依据,以D-半乳糖(500 mg/kg)在小鼠颈背部皮下连续注射4周建立小鼠衰老模型后,将小鼠随机分为模型对照组(生理盐水)、阳性对照组(维生素C 200 mg/kg)和紫苏籽油高(5 mL/kg)、中(2.5 mL/kg)、低(1.25 mL/kg)剂量组,连续灌胃4周,记录小鼠体质量及行为变化,通过转棒法和金属网法检测小鼠的协调运动能力,测定小鼠主要脏器(脑、胸腺、脾脏)指数以及小鼠血清和脑组织匀浆中谷胱甘肽过氧化物酶(GSH-Px)活力和丙二醛(MDA)含量 ...
王荣1,2,3,王娜娜1,2,3,杨宽1,2,3,刘自群1,秦蓓1,2,3 WANG Rong1,2,3,WANG Nana1,2,3, YANG Kuan1,2,3, LIU Ziqun1,QIN Bei1,2,3
doaj   +1 more source

The Association between Antihypertensive Drugs and Falls in Older Adults in Amirkola, Northern Iran

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2022
Background and Objective: Being familiar with the factors that are effective in causing falls plays an important role in reducing the issues and costs related to its treatment. Considering the contradictory results about the use of antihypertensive drugs
M Kamali   +4 more
doaj  

Retrospective research of the range of combined antihypertensive drugs in Ukraine in 2022 compared to 2015

open access: yesФармацевтичний журнал, 2022
The prevalence of arterial hypertension is reaching alarming proportions in low- and middle-income countries, including Ukraine. A sufficiently high prevalence of hypertension among people of the working age creates an additional economic burden on the ...
M. B. Demchuk   +2 more
doaj   +1 more source

Strategy for Depressing Antihypertensive Drugs in Very Elderly and Fragile Patients: A Review of Contemporary Data

open access: yesАрхивъ внутренней медицины
Antihypertensive drugs reduce the risk of stroke and cardiovascular disease in all age groups. However, in elderly and frail patients, antihypertensive treatment is associated with an increased risk of hypotension, syncope, acute kidney injury and ...
O. N. Antropova   +2 more
doaj   +1 more source

Real-World Prescribing Patterns for Hypertensive Children in China from 2018 to 2021: A Cross-Sectional Multicenter Study

open access: yesRisk Management and Healthcare Policy, 2023
Qin Qian,* Yu-Zhen Wang,* Lian-Di Kan,* Jie Chen, Chen Wang, Gang Han, Liu-Cheng Li, Wei-Jian Lou Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, People’s Republic of China&ast ...
Qian Q   +7 more
doaj  

Use and spending on antihypertensive and antihyperlipidemic drugs by age.

open access: yes, 2021
Use and spending on antihypertensive and antihyperlipidemic drugs by age.
Jihye Shin (714449)   +3 more
core   +1 more source

Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?

open access: yesPLoS ONE, 2016
BackgroundThe increase in angiotensin II (Ang II) formation by selected antihypertensive drugs is said to exhibit neuroprotective properties, but this translation into improvement in clinical outcomes has been inconclusive.
Wen Yea Hwong   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy